Bank of New York Mellon Corp raised its position in Clorox Company (The) (NYSE:CLX) by 0.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,062,319 shares of the company’s stock after buying an additional 7,222 shares during the period. Bank of New York Mellon Corp owned approximately 0.82% of Clorox Company (The) worth $140,129,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of CLX. Parkside Financial Bank & Trust lifted its position in shares of Clorox Company (The) by 3.8% during the second quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock worth $107,000 after purchasing an additional 29 shares during the last quarter. Valley National Advisers Inc. lifted its position in shares of Clorox Company (The) by 0.6% during the second quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock worth $115,000 after purchasing an additional 5 shares during the last quarter. Blue Chip Partners Inc. lifted its position in shares of Clorox Company (The) by 3.9% during the second quarter. Blue Chip Partners Inc. now owns 941 shares of the company’s stock worth $125,000 after purchasing an additional 35 shares during the last quarter. Sun Life Financial INC lifted its position in shares of Clorox Company (The) by 10,344.4% during the second quarter. Sun Life Financial INC now owns 940 shares of the company’s stock worth $125,000 after purchasing an additional 931 shares during the last quarter. Finally, Acrospire Investment Management LLC bought a new position in shares of Clorox Company (The) during the second quarter worth about $133,000. 72.74% of the stock is owned by institutional investors.

Several equities research analysts recently weighed in on CLX shares. Jefferies Group LLC reiterated a “hold” rating and set a $132.00 price objective on shares of Clorox Company (The) in a research note on Wednesday, November 1st. Zacks Investment Research lowered shares of Clorox Company (The) from a “hold” rating to a “sell” rating in a research note on Wednesday, October 4th. Morgan Stanley dropped their price objective on shares of Clorox Company (The) from $138.00 to $128.00 and set an “equal weight” rating on the stock in a research note on Thursday, November 2nd. Royal Bank Of Canada reiterated a “hold” rating and set a $115.00 price objective on shares of Clorox Company (The) in a research note on Sunday, October 8th. Finally, BMO Capital Markets reiterated a “buy” rating and set a $150.00 price objective on shares of Clorox Company (The) in a research note on Thursday, October 5th. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the stock. Clorox Company (The) presently has a consensus rating of “Hold” and a consensus target price of $128.72.

In related news, SVP Matthew T. Laszlo sold 20,051 shares of the firm’s stock in a transaction that occurred on Wednesday, November 8th. The shares were sold at an average price of $130.46, for a total value of $2,615,853.46. Following the completion of the transaction, the senior vice president now owns 10,896 shares of the company’s stock, valued at approximately $1,421,492.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Dawn C. Willoughby sold 2,158 shares of the firm’s stock in a transaction that occurred on Tuesday, August 29th. The stock was sold at an average price of $138.00, for a total transaction of $297,804.00. The disclosure for this sale can be found here. Company insiders own 1.00% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The legal version of this piece of content can be viewed at https://theolympiareport.com/2017/11/22/bank-of-new-york-mellon-corp-has-140-13-million-holdings-in-clorox-company-the-clx.html.

Clorox Company (CLX) opened at $135.15 on Wednesday. The stock has a market cap of $17,353.85, a P/E ratio of 24.25, a PEG ratio of 3.67 and a beta of 0.39. Clorox Company has a 1-year low of $112.28 and a 1-year high of $141.76. The company has a quick ratio of 0.77, a current ratio of 1.10 and a debt-to-equity ratio of 3.02.

Clorox Company (The) (NYSE:CLX) last issued its earnings results on Wednesday, November 1st. The company reported $1.46 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.41 by $0.05. The firm had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.48 billion. Clorox Company (The) had a net margin of 11.84% and a return on equity of 161.59%. The firm’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same period last year, the firm posted $1.36 earnings per share. analysts anticipate that Clorox Company will post 5.58 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be issued a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a yield of 2.49%. The ex-dividend date of this dividend is Tuesday, January 23rd. Clorox Company (The)’s payout ratio is 61.88%.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.